Lind M - Search Results

1

Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer.

Baka S, Ashcroft L, Anderson H, Lind M, Burt P, Stout R, Dowd I, Smith D, Lorigan P, Thatcher N. Baka S, et al. Among authors: lind m. J Clin Oncol. 2005 Apr 1;23(10):2136-44. doi: 10.1200/JCO.2005.01.003. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15713598 Clinical Trial.

2

Carboplatin in small cell lung cancer.

Thatcher N, Lind M. Thatcher N, et al. Among authors: lind m. Semin Oncol. 1990 Feb;17(1 Suppl 2):40-8. Semin Oncol. 1990. PMID: 2154859 Review.

3

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.

Lind MJ, Gomm S, Simmonds AP, Ashcroft L, Kamthan A, Gurney H, Thatcher N. Lind MJ, et al. Cancer Chemother Pharmacol. 1991;28(2):142-4. doi: 10.1007/BF00689705. Cancer Chemother Pharmacol. 1991. PMID: 1647893

4

Novel approaches with ifosfamide in small cell lung cancer.

Thatcher N, Lind M, De Campos E, Cerny T. Thatcher N, et al. Among authors: lind m. Semin Oncol. 1992 Feb;19(1 Suppl 1):68-77. Semin Oncol. 1992. PMID: 1329215 Review.

5

A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).

Cerny T, Lind M, Thatcher N, Swindell R, Stout R. Cerny T, et al. Among authors: lind m. Br J Cancer. 1989 Aug;60(2):258-61. doi: 10.1038/bjc.1989.265. Br J Cancer. 1989. PMID: 2548560 Free PMC article.

6

Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.

Thatcher N, Lind M, Stout R, Payne C, Carroll KB, Campbell C, Moussalli H. Thatcher N, et al. Among authors: lind m. Br J Cancer. 1989 Jul;60(1):98-101. doi: 10.1038/bjc.1989.228. Br J Cancer. 1989. PMID: 2553090 Free PMC article.

7

Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.

Anderson H, Lind MJ, Thatcher N, Swindell R, Woodcock A, Carroll KB. Anderson H, et al. Among authors: lind mj. Cancer Chemother Pharmacol. 1990;26(1):71-4. doi: 10.1007/BF02940299. Cancer Chemother Pharmacol. 1990. PMID: 2157555

8

Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.

Kamthan AG, Lind MJ, Thatcher N, Steward WP, Bronchud MH, Ranson MR, Stout R. Kamthan AG, et al. Among authors: lind mj. Eur J Cancer. 1990;26(6):691-4. doi: 10.1016/0277-5379(90)90118-d. Eur J Cancer. 1990. PMID: 2168191

9

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.

Thatcher N, Smith DB, Lind MJ, Anderson H, Barclay J, Chopra MP, Fitzgerald MD. Thatcher N, et al. Among authors: lind mj. Cancer. 1988 Jan 1;61(1):14-8. doi: 10.1002/1097-0142(19880101)61:1<14::aid-cncr2820610104>3.0.co;2-q. Cancer. 1988. PMID: 3334940

10

The effect of age on the pharmacokinetics of ifosfamide.

Lind MJ, Margison JM, Cerny T, Thatcher N, Wilkinson PM. Lind MJ, et al. Br J Clin Pharmacol. 1990 Jul;30(1):140-3. doi: 10.1111/j.1365-2125.1990.tb03754.x. Br J Clin Pharmacol. 1990. PMID: 2167716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,122 results

Search Page

Filters